Moreover, it was reported that EzH2 downregulation could reduce growth of invasive breast carcinoma [15], tumor angiogenesis [20] and in vitro cell migration/invasion of CRC cell lines [13, 21]. Here, EZH2 is linked to invasive breast carcinoma.